Zynerba Pharmaceuticals, Inc. [ZYNE]

Source: 

Company Overview

Zynerba Pharmaceuticals, Inc is the leader in pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. We are committed to improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, or FXS, and chromosome 22q11.2 deletion syndrome, or 22q.